UK-Edinburgh: research and development consultancy services

Watch this tender

Summary

Please scroll down for full details
Threshold: 
OJEU
Organisation: 
University of Edinburgh
Main activities: 
Education
NUTS Code: 
Edinburgh, City of (UKM25)
Type: 
Contract notice
CPV Code: 
73200000 Research and development consultancy services
Market: 
Service contract
Award criteria: 
The most economic tender
Published: 
Thursday, September 13, 2012
Deadline: 
Friday, October 12, 2012 - 10:00
Tender ID: 
2012/S 176-290596
Related Documents: 

Directive 2004/18/EC

Section I: Contracting authority

Section II: Object of the contract

  • II.1) Description

    • II.1.1) Title attributed to the contract by the contracting authority:

      EC 0568. Medical device development.

    • II.1.2) Type of contract and location of works, place of delivery or of performance

      Services

      Service category No 8: Research and development services

      Main site or location of works, place of delivery or of performance: Edinburgh.

      NUTS code UKM25

    • II.1.3) Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

      The notice involves a public contract

    • II.1.4) Information on framework agreement

      Not provided

    • II.1.5) Short description of the contract or purchase(s)

      1. The University of Edinburgh ("the Buyer") invites competitive tenders for the design and development of a novel diagnostic medical device. This procurement process is to address the initial device development needs of a new research and development project, which will be led by a University appointed Project Team. The appointed tenderer will work in partnership with the Buyer and the aforementioned team to plan, design, develop, manufacture and test two identical prototype diagnostic devices for preliminary clinical testing. Additional iterative development of the device is likely after the initial research and development project and this will be addressed in the tender;

      2. This document addresses Stage 1 of a two-stage procurement process, which is explained in the later paragraphs of this section;

      3. The project will initiate in January 2013 and will run for 24 months, assuming that all objectives / milestone are met. Phase A will have a duration of 3 months and will focus on software development. Phase B will have a duration of 2.5 months and this will focus on technology selection. The design and development part of this project is due for completion at the end of October 2013 and this stage of the project will be referred to as Phase C. The clinical testing for the project will comment November 2013 and this stage of the project will be referred to as Phase D. Phase D is not subject to this tender;

      4. There are specific "go/no-go" milestones at the end of each Phase of the project. If a milestone is not successfully achieved then the project will be terminated;

      5. Two bespoke prototype medical devices will be required to be designed and built to the Buyer project team’s specifications. Offers are being sought for the design and development of these bespoke devices. Tenderers are invited to propose their own solutions and / or developments of the prototypes to achieving the best outcome regarding efficient manufacture of the novel medical device;

      6. A description of the indication and the detailed specification of the novel medical device will not be available during the Stage 1 procurement process; this will only be available to short listed tenderers. The equipment specifications are indicative and for guidance only and are likely to be developed during the procurement process. The final designs and the fitness for purpose of the final product shall be the responsibility of the Tenderer. The Phases are described further below.

      Phase A: clinical data analysis and proof of concept.

      Phase B: technology selection.

      Phase C: prototype device development.

      6.1 The tenderers shall also be required to provide a range of services in relation to the design and development of a novel diagnostic medical device including project management, design and / or sample production, logistics, installation, commissioning, snagging, training, warranty back up for the equipment supplied in all of the above;

      6.2 The prototype diagnostic medical devices offered will be required to be tested and proved fit for purpose for clinical use over the life of the product, expected to be at least 3 years.

      7. This tender will follow a two stage restricted procurement procedure as explained below:

      — First stage procurement procedure; pre-qualification stage which will require tenderers to complete questionnaires as contained within or supplied with this document,

      — Selection: by using the results from the questionnaires, contained within this document, tenderers will be short listed,

      — Second stage procurement procedure; invitation to tender stage where only short listed tenderers, who have returned a countersigned NDA shall be issued with the ITT document, containing a full specification and awards shall be made based on the tender offers made in the second stage.

      8. The restricted process has been adopted to ensure only tenderers that have the capacity to design and develop the prototype devices, then provide on-going service back up to the highest standard, are short-listed to provide tender offers;

      9. A maximum of 5 tenderers shall be short listed, on the basis that five or more competent and acceptable offers are received;

      10. As part of the first stage submission the tenderer shall sign and return the non-disclosure agreement.

    • II.1.6) Common procurement vocabulary (CPV)

      73200000

    • II.1.7) Information about Government Procurement Agreement (GPA)

      The contract is covered by the Government Procurement Agreement (GPA): yes

    • II.1.8) Lots

      This contract is divided into lots: no

    • II.1.9) Information about variants

      Variants will be accepted: no

  • II.2) Quantity or scope of the contract

    • II.2.1) Total quantity or scope:

      Phase A: clinical data analysis and proof of concept.

      Phase B: technology selection.

      Phase C: prototype device development.

    • II.2.2) Information about options

      Options: no

    • II.2.3) Information about renewals

      This contract is subject to renewal: no

  • II.3) Duration of the contract or time limit for completion

    Starting 10.1.2013. Completion 8.1.2015

Section III: Legal, economic, financial and technical information

  • III.1) Conditions relating to the contract

    • III.1.1) Deposits and guarantees required:

      Not provided

    • III.1.2) Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:

      Milestone Based.

    • III.1.3) Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

      Jointly and severally liable.

    • III.1.4) Other particular conditions

      The performance of the contract is subject to particular conditions: no

  • III.2) Conditions for participation

    • III.2.1) Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers

      Information and formalities necessary for evaluating if the requirements are met: Short listed tenderers shall be required to comply with a range of Mandatory and Minimum Standards which are detailed in the tender document.

    • III.2.2) Economic and financial ability

      Information and formalities necessary for evaluating if the requirements are met: Short listed tenderers shall be required to comply with a range of Mandatory and Minimum Standards which are detailed in the tender document.

      Minimum level(s) of standards possibly required: Short listed tenderers shall be required to comply with a range of Mandatory and Minimum Standards which are detailed in the tender document.

    • III.2.3) Technical capacity

      Information and formalities necessary for evaluating if the requirements are met:

      Short listed tenderers shall be required to comply with a range of Mandatory and Minimum Standards which are detailed in the tender document.

      Minimum level(s) of standards possibly required:

      Short listed tenderers shall be required to comply with a range of Mandatory and Minimum Standards which are detailed in the tender document.

    • III.2.4) Information about reserved contracts

      Not provided

  • III.3) Conditions specific to services contracts

    • III.3.1) Information about a particular profession

      Not provided

    • III.3.2) Staff responsible for the execution of the service

      Legal persons should indicate the names and professional qualifications of the staff responsible for the execution of the service: yes

Section IV: Procedure

  • IV.1) Type of procedure

    • IV.1.1) Type of procedure

      Restricted

    • IV.1.2) Limitations on the number of operators who will be invited to tender or to participate

      Envisaged minimum number 5

      Objective criteria for choosing the limited number of candidates: Short listed tenderers shall be required to comply with a range of Mandatory and Minimum Standards which are detailed in the tender document.

    • IV.1.3) Reduction of the number of operators during the negotiation or dialogue

      Not provided

  • IV.2) Award criteria

    • IV.2.1) Award criteria

      The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document

    • IV.2.2) Information about electronic auction

      An electronic auction will be used: no

  • IV.3) Administrative information

    • IV.3.1) File reference number attributed by the contracting authority:

      EC/0568 Medical Device Development

    • IV.3.2) Previous publication(s) concerning the same contract

      Not provided

    • IV.3.3) Conditions for obtaining specifications and additional documents or descriptive document

      Time limit for receipt of requests for documents or for accessing documents: 11.10.2012

    • IV.3.4) Time limit for receipt of tenders or requests to participate

      12.10.2012 - 10:00

    • IV.3.5) Date of dispatch of invitations to tender or to participate to selected candidates

      26.10.2012

    • IV.3.6) Language(s) in which tenders or requests to participate may be drawn up

      English.

    • IV.3.7) Minimum time frame during which the tenderer must maintain the tender

      Not provided

    • IV.3.8) Conditions for opening tenders

      Not provided

Section VI: Complementary information

  • VI.1) Information about recurrence

    Not provided

  • VI.2) Information about European Union funds

    Not provided

  • VI.3) Additional information

    2.1 The University of Edinburgh operates an e-tendering system that maintains all returned pre-qualification questionnaires (or tender offers as appropriate) in a secure and confidential "storage area" until the closing date has elapsed. University staff do not have access to the completed questionnaires until the closing date for Stage 1 has elapsed. Following the closing date, all returns are opened at the same time.

    2.2 We will advise all participating tenderers of clarifications via the In Tend correspondence link. It is strongly recommend that Tenderers ensure that all relevant staff have access to In Tend to ensure that advice issued by the University of Edinburgh, is received by the correct person and acted upon quickly.

    2.3 It is vitally important that all communications are made via the In Tend system. Correspondence within the In Tend system is automatically recorded within the systems database. Other methods e.g. emails, are not automatically recorded and may result in a delayed or no response.

    2.4 Direct communication with End Users or the Project Team during either stage of the tender process is not permitted.

    2.5 Tenders shall be submitted electronically. Pre-qualification documents (or tender offers as appropriate) must not be sent to any other address in the University. Failure to comply may result in the tender submission being rejected. The link to the University’s web site is:

    https://www.in-tendhost.com/edinburghuni/

    2.6 Following registration, the tenderer will be provided with a user id number to access our e tender hosting service within the In Tend system. Once logged onto the site, tenderers can then down load the ITT. Tenderers can to upload their offer details back onto the secure site when ready to do so.

    2.7 Tenders cannot be up loaded after the closing time and will, therefore, be rejected.

    2.8 The Buyer is required to reject any offer from Tenderers that does not meet the pre-qualification selection criterion,

    2.9 All responses shall be in Microsoft Word or Excel 2000 format. Brochures, drawings, certificates etc should be supplied in PDF format (PDF shall be copy enabled).

    2.10 The delivery and commissioning arrangements for the equipment shall be subject to particular procedures that shall be described in detail in the second stage ITT document.

    (SC Ref:238776).

  • VI.4) Procedures for appeal

    • VI.4.1) Body responsible for appeal procedures

      Not provided

    • VI.4.2) Lodging of appeals

      Not provided

    • VI.4.3) Service from which information about the lodging of appeals may be obtained

      Not provided

  • VI.5) Date of dispatch of this notice:

    11.9.2012